Sign up to save your podcasts
Or
Share A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis
Dr. Shuvro Roy talks with Dr. Daniel Blockmans about the efficacy and safety of upadacitinib as a treatment option for giant-cell arteritis.
Read the related article in The New England Journal of Medicine.
Disclosures can be found at Neurology.org.
View all episodes
By American Academy of Neurology
4.7
284284 ratings
Dr. Shuvro Roy talks with Dr. Daniel Blockmans about the efficacy and safety of upadacitinib as a treatment option for giant-cell arteritis.
Read the related article in The New England Journal of Medicine.
Disclosures can be found at Neurology.org.
More shows like Neurology® Podcast
View all
NEJM This Week
324 Listeners
JAMA Clinical Reviews
498 Listeners
Practical Neurology Podcast
47 Listeners
Mayo Clinic Talks
297 Listeners
The Curbsiders Internal Medicine Podcast
3,357 Listeners
JAMA Neurology Author Interviews
13 Listeners
Core IM | Internal Medicine Podcast
1,144 Listeners
Neurology Today in 5
24 Listeners
Annals On Call Podcast
191 Listeners
The Clinical Problem Solvers
515 Listeners
Neurology Minute
138 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
369 Listeners
Neurology Exam Prep Podcast
192 Listeners
The Curious Clinicians
374 Listeners
Continuum Audio
83 Listeners